These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 31829231)

  • 1. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
    Nguyen VHL; Hough R; Bernaudo S; Peng C
    J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wnt/β-catenin pathway in ovarian cancer: a review.
    Arend RC; Londoño-Joshi AI; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2013 Dec; 131(3):772-9. PubMed ID: 24125749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling.
    Schmitz Y; Rateitschak K; Wolkenhauer O
    Cell Signal; 2013 Nov; 25(11):2210-21. PubMed ID: 23872074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
    Burkhalter RJ; Westfall SD; Liu Y; Stack MS
    J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
    Usongo M; Li X; Farookhi R
    Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy.
    Li RN; Liu B; Li XM; Hou LS; Mu XL; Wang H; Linghu H
    Sci Rep; 2017 Aug; 7(1):9285. PubMed ID: 28839145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells.
    Barghout SH; Zepeda N; Xu Z; Steed H; Lee CH; Fu Y
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):173-8. PubMed ID: 26522223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
    Brantjes H; Barker N; van Es J; Clevers H
    Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway.
    Pei L; Zhao F; Zhang Y
    Apoptosis; 2024 Feb; 29(1-2):210-228. PubMed ID: 38087046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
    Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
    Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium.
    Feng Y; Sakamoto N; Wu R; Liu JY; Wiese A; Green ME; Green M; Akyol A; Roy BC; Zhai Y; Cho KR; Fearon ER
    PLoS Genet; 2015 Nov; 11(11):e1005638. PubMed ID: 26528816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
    Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
    Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin regulation of beta-catenin signaling in ovarian carcinoma.
    Burkhalter RJ; Symowicz J; Hudson LG; Gottardi CJ; Stack MS
    J Biol Chem; 2011 Jul; 286(26):23467-75. PubMed ID: 21518759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.